ArticleInvestigational new drugs2021

Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance).

Nguyen H Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.